Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis
Condition: Bacterial VaginosisInterventions: Drug: 5% Monolaurin Vaginal Gel; Other: PlaceboSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified March 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials